|BP (Alendronate [oral], Risedronate [oral]; Ibandronate [oral/ IV], Zoledronic acid [IV])|We strongly recommend OP treatment for those at moderate, high, or very high risk of fracture. We strongly recommend oral BP over no treatment in high and very high fracture risk due to fracture reduction in GIOP. We conditionally recommend IV BP, ROM, RAL over no treatment in high and very high risk of fracture. In moderate risk, we conditionally recommend BP, DEN, or PTH/PTHrP in no preferred order among these agents.|We conditionally recommend treatment for those at moderate or very high risk of fracture with oral or IV BP,‡ PTH/PTHrP,§ or DEN§#|